FTRE Fortrea Holdings Inc. logo

FTRE Fortrea Holdings Inc.

Healthcare
$13.24+0.00%OpenMarket Cap: $1.25B

As of 2026-05-26

Valuation

View Details

P/E (TTM)

PEG

P/B

2.29

P/S

0.46

EV/EBITDA

-4.14

DCF Value

$-4.91

FCF Yield

15.2%

Div Yield

0.0%

Margins & Returns

Gross Margin

16.0%

Operating Margin

-0.5%

Net Margin

-16.5%

ROE

-79.1%

ROA

-16.7%

ROIC

-0.8%

Financials

View All
PeriodRevenueNet IncomeEPS
Q1 null$636.5M$-23.6M$
Q4 null$660.5M$-32.5M$
FY null$2.72B$-986.2M$
Q3 null$701.3M$-15.9M$

Analyst Ratings

View All

Consensus

Hold

Target (Consensus)

$18.57

Target (Median)

$19.00

Target Range

$14.00 - $25.00

0 Strong Buy5 Buy6 Hold0 Sell2 Strong Sell
MizuhoNeutral
2026-05-12
BarclaysEqual Weight
2026-05-06
CitigroupBuy
2026-05-06
Evercore ISI GroupOutperform
2026-04-08
TD CowenBuy
2026-03-09

Trading Activity

Insider Trades

View All
Parks Robertofficer: Chief Accounting Officer
SellWed May 20
NEUPERT PETER Mdirector
SellMon May 18
Russell Erin Ldirector
SellTue Mar 24
Morais Mark A.officer: Chief Operating Officer
SellTue Mar 17
Morais Mark A.officer: Chief Operating Officer
SellTue Mar 17

Company Info

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

Beta

1.91

Fortrea Holdings Inc., a contract research organization, primarily engages in the provision of biopharmaceutical product and medical device development services worldwide. It operates through two segments: Clinical Services and Enabling Services. The Clinical Services segment provides across the clinical pharmacology and clinical development spectrum. The Enabling Services segment provides patient access and clinical trial technology solutions to customers that streamline complex randomization and optimize the trial drug supply process. The company offers delivery models that include full service, functional service provider, and hybrid service structures. It also offers phase I-IV clinical trial management, differentiated technology enabled trial solutions, and post approval services. The company serves pharmaceutical, biotechnology, and medical device organizations. Fortrea Holdings Inc. was incorporated in 2023 and is based in Durham, North Carolina.

Peers